Acura Pharmaceuticals Operating Income 2010-2021 | ACUR

Acura Pharmaceuticals operating income from 2010 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Acura Pharmaceuticals Annual Operating Income
(Millions of US $)
2021 $-1
2020 $-1
2019 $-1
2018 $-4
2017 $-5
2016 $-7
2015 $-4
2014 $-12
2013 $-14
2012 $-10
2011 $11
2010 $-13
2009 $-14
Acura Pharmaceuticals Quarterly Operating Income
(Millions of US $)
2021-12-31 $0
2021-09-30 $-1
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $-1
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $-1
2019-03-31 $-1
2018-12-31 $0
2018-09-30 $-1
2018-06-30 $-1
2018-03-31 $-1
2017-12-31 $-2
2017-09-30 $-2
2017-06-30 $-2
2017-03-31 $1
2016-12-31 $2
2016-09-30 $-2
2016-06-30 $-3
2016-03-31 $-3
2015-12-31 $-1
2015-09-30 $-2
2015-06-30 $-2
2015-03-31 $2
2014-12-31 $-2
2014-09-30 $-3
2014-06-30 $-3
2014-03-31 $-4
2013-12-31 $-3
2013-09-30 $-3
2013-06-30 $-3
2013-03-31 $-4
2012-12-31 $-3
2012-09-30 $-2
2012-06-30 $-2
2012-03-31 $-2
2011-12-31 $-2
2011-09-30 $-2
2011-06-30 $17
2011-03-31 $-3
2010-12-31 $-3
2010-09-30 $-3
2010-06-30 $-3
2010-03-31 $-4
2009-12-31 $-4
2009-09-30 $-4
2009-06-30 $-3
2009-03-31 $-2
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.001B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $18.584B 6.80
Dr Reddy's Laboratories (RDY) India $11.578B 22.09
BridgeBio Pharma (BBIO) United States $7.257B 0.00
Bausch Health Cos (BHC) Canada $1.822B 1.31
Supernus Pharmaceuticals (SUPN) United States $1.814B 16.87
Amphastar Pharmaceuticals (AMPH) United States $1.193B 7.22
Taysha Gene Therapies (TSHA) United States $0.504B 0.00
Personalis (PSNL) United States $0.376B 0.00
Assembly Biosciences (ASMB) United States $0.108B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Sol-Gel Technologies (SLGL) Israel $0.000B 0.00
Teligent (TLGT) United States $0.000B 0.00